Merck & Co., Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Merck & Co., Inc.
CIK #0000310158
CIK Period
0000310158
Sector Form 13F Holdings Value ($M)
Moderna Inc 117.3
Personalis Inc 89.5
Kymera Therapeutics Inc 64.3
Alector Inc 7.6
Sutro Biopharma Inc 6.8
Evaxion Biotech A/S 4.5
Signal Genetics Inc 1.8
Xilio Therapeutics Inc 0.9
Bionomics Limited/Fi 0.0
Berry Only Inc 0.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
10-K [0000310158]
10-Q [0000310158]
13F-HR [0000310158]
3 [0000310158]
4 [0000310158]
5 [0000310158]
8-K [0000310158]
SC 13D [0000310158]
SC 13G [0000310158]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Merck & Co Inc [2026-04-30]
Merck & Co Inc Personalis Inc [2024-12-23]
Merck & Co Inc Evaxion Biotech A/S [2024-01-23]
Merck & Co Inc 4D Pharma PLC [2022-02-02]
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04]
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04]
Merck & Co Inc Arqule Inc [2019-12-16]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Merck & Co Inc Alector Inc [2019-02-14]
Merck & Co Inc Sutro Biopharma Inc [2018-10-04]
View All
Form 3/4/5 Subject 2011 - 2026
Merck & Co., Inc.
Coe Mary Ellen
Seidman Christine E
Karsanbhai Surendralal Lanca
Thulin Inge G
Russo Patricia F
Rothman Paul
Mayo Stephen
Lavizzo-Mourey RISA J
Glocer Thomas H
View All
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com